Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 385082, 9 pages
http://dx.doi.org/10.1155/2014/385082
Research Article

Angiotensin Converting Enzyme Inhibition Reduces Cardiovascular Responses to Acute Stress in Myocardially Infarcted and Chronically Stressed Rats

1Department of Experimental and Clinical Physiology, Medical University of Warsaw, Ulica Pawinskiego 3c, 02-106 Warsaw, Poland
2Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Ulica Banacha 1a, 02-097 Warsaw, Poland

Received 28 February 2014; Revised 29 May 2014; Accepted 1 June 2014; Published 19 June 2014

Academic Editor: Alain Broccard

Copyright © 2014 A. Cudnoch-Jedrzejewska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Fabiani, D. T. Dinh, L. Nassis, and C. I. Johnston, “Angiotensin-converting enzyme: basic properties, distribution, and functional role,” in Hypertension: A Companion to Brenner and Rector’s the Kidney, S. Oparil and M. A. Weber, Eds., pp. 90–100, WB Saunders, Philadelphia, Pa, USA, 2000. View at Google Scholar
  2. D. Fournier, F. C. Luft, M. Bader, D. Ganten, and M. A. Andrade-Navarro, “Emergence and evolution of the renin-angiotensin-aldosterone system,” Journal of Molecular Medicine, vol. 90, no. 5, pp. 495–508, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Pfeffer, J. J. V. McMurray, E. J. Velazquez et al., “Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both,” The New England Journal of Medicine, vol. 349, no. 20, pp. 1893–1906, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Schrader, A. Kulschewski, and A. Dendorfer, “Inhibition of the renin-angiotensin system and the prevention of stroke,” The American Journal of Cardiovascular Drugs, vol. 7, no. 1, pp. 25–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Ferrari, “RAAS inhibition and mortality in hypertension: from pharmacology to clinical evidence,” Kardiologia Polska, vol. 71, no. 1, pp. 1–7, 2013. View at Google Scholar · View at Scopus
  6. S. Ueda, “New approaches to blockade of the renin-angiotensin-aldosterone system: evidence from randomized controlled trials (RCTs) of angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers-questions remain unsolved,” Journal of Pharmacological Sciences, vol. 113, no. 4, pp. 292–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Makani, S. Bangalore, K. A. Desouza, A. Shah, and F. H. Messerli, “Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials,” British Medical Journal, vol. 346, no. 7896, article f360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Shah, K. A. Mergenhagen, and K. Kellick, “Effectiveness and safety of dual renin-angiotensin system blockade: a comparison between younger and older cohorts,” Consultant Pharmacist, vol. 28, no. 6, pp. 383–389, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Yang, Z.-X. Xi, Y. Wan, H. Wang, and G. Bi, “Changes in circulating and tissue angiotensin II during acute and chronic stress,” Biological Signals, vol. 2, no. 3, pp. 166–172, 1993. View at Google Scholar · View at Scopus
  10. I. Armando, S. Volpi, G. Aguilera, and J. M. Saavedra, “Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress,” Brain Research, vol. 1142, no. 20, pp. 92–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Saavedra and J. Benicky, “Brain and peripheral angiotensin II play a major role in stress,” Stress, vol. 10, no. 2, pp. 185–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Pavel, J. Benicky, Y. Murakami, E. Sanchez-Lemus, and J. M. Saavedra, “Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo,” Annals of the New York Academy of Sciences, vol. 1148, pp. 360–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Saavedra, E. Sánchez-Lemus, and J. Benicky, “Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications,” Psychoneuroendocrinology, vol. 36, no. 1, pp. 1–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Saiki, T. Watanabe, N. Tan, M. Matsuzaki, and S. Nakamura, “Role of central ANG II receptors in stress-induced cardiovascular and hyperthermic responses in rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 272, no. 1, part 2, pp. R26–R33, 1997. View at Google Scholar · View at Scopus
  15. R. De Matteo, G. A. Head, and D. N. Mayorov, “Angiotensin II in dorsomedial hypothalamus modulates cardiovascular arousal caused by stress but not feeding in rabbits,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 290, no. 1, pp. R257–R264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. N. Mayorov and G. A. Head, “AT1 receptors in the RVLM mediate pressor responses to emotional stress in rabbits,” Hypertension, vol. 41, no. 5, pp. 1168–1173, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Zhang, B. S. Huang, and F. H. H. Leenen, “Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 276, no. 5, part 2, pp. H1608–H1615, 1999. View at Google Scholar · View at Scopus
  18. A. Cudnoch-Jedrzejewska, J. Dobruch, L. Puchalska, and E. Szczepańska-Sadowska, “Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the post-infarct state,” Regulatory Peptides, vol. 142, no. 3, pp. 86–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Cudnoch-Jedrzejewska, E. Szczepanska-Sadowska, J. Dobruch et al., “Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: relevance to stress and interaction with vasopressin,” Stress, vol. 11, no. 4, pp. 290–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Unger, “Targeting cardiovascular protection: the concept of dual renin-angiotensin system control,” MedGenMed Medscape General Medicine, vol. 10, supplement, p. S4, 2008. View at Google Scholar · View at Scopus
  21. A. Kuoppala, K. A. Lindstedt, J. Saarinen, P. T. Kovanen, and J. O. Kokkonen, “Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 278, no. 4, pp. H1069–H1074, 2000. View at Google Scholar · View at Scopus
  22. J. E. Dimsdale, “Psychological stress and cardiovascular disease,” Journal of the American College of Cardiology, vol. 51, no. 13, pp. 1237–1246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Elkouri, P. Demers, M. G. Sirois, A. Couturier, and R. Cartier, “Effect of chronic exercise and angiotensin-converting enzyme inhibition on rodent thoracic aorta,” Journal of Cardiovascular Pharmacology, vol. 44, no. 5, pp. 582–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. L. M. Swislocki, T. L. Kinney Lapier, D. T. Khuu, K. Y. Fann, M. Tait, and K. J. Rodnick, “Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats,” The American Journal of Hypertension, vol. 12, no. 6, pp. 581–589, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Dobruch, A. Cudnoch-Jedrzejewska, and E. Szczepanska-Sadowska, “Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction,” Stress, vol. 8, no. 4, pp. 273–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Selye, E. Bajusz, S. Grasso, and P. Mendell, “Simple techniques for the surgical occlusion of coronary vessels in the rat,” Angiology, vol. 11, pp. 398–407, 1960. View at Publisher · View at Google Scholar
  27. M. A. Pfeffer, J. M. Pfeffer, C. Steinberg, and P. Finn, “Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril,” Circulation, vol. 72, no. 2, pp. 406–412, 1985. View at Google Scholar · View at Scopus
  28. A. Cudnoch-Jȩdrzejewska, E. Szczepańska-Sadowska, J. Dobruch et al., “Fluid consumption, electrolyte excretion and heart remodeling in rats with myocardial infarct maintained on regular and high sodium intake,” Journal of Physiology and Pharmacology, vol. 56, no. 4, pp. 599–610, 2005. View at Google Scholar · View at Scopus
  29. A. J. Grippo, J. Francis, T. G. Beltz, R. B. Felder, and A. K. Johnson, “Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia,” Physiology and Behavior, vol. 84, no. 5, pp. 697–706, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Cudnoch-Jedrzejewska, E. Szczepanska-Sadowska, J. Dobruch, R. Gomolka, and L. Puchalska, “Brain vasopressin V1 receptors contribute to enhanced cardiovascular responses to acute stress in chronically stressed rats and rats with myocardial infarcton,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 298, no. 3, pp. R672–R680, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. F. H. H. Leenen, B. Yuan, and B. S. Huang, “Brain “ouabain” and angiotensin II contribute to cardiac dysfunction after myocardial infarction,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 277, no. 5, part 2, pp. H1786–H1792, 1999. View at Google Scholar · View at Scopus
  32. D. Curran-Everett and D. J. Benos, “Guidelines for reporting statistics in journals published by the American Physiological Society,” Physiological Genomics, vol. 18, no. 3, pp. 249–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Ludbrook, “Repeated measurements and multiple comparisons in cardiovascular research,” Cardiovascular Research, vol. 28, no. 3, pp. 303–311, 1994. View at Google Scholar · View at Scopus
  34. S. Y. Chai, J. Zhuo, and F. A. O. Mendelsohn, “Localization of components of the renin-angiotensin system and site of action of inhibitors,” Arzneimittel-Forschung/Drug Research, vol. 43, no. 2A, pp. 214–221, 1993. View at Google Scholar · View at Scopus
  35. M. Ahmad, R. White, J. Tan, B. S. Huang, and F. H. Leenen, “Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction,” Journal of Cardiovascular Pharmacology, vol. 51, no. 6, pp. 565–572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Fagard, P. Lijnen, L. Vanhees, and A. Amery, “Hemodynamic response to converting enzyme inhibition at rest and exercise in humans,” Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, vol. 53, no. 3, pp. 576–581, 1982. View at Google Scholar · View at Scopus
  37. P. Geppetti, M. G. Spillantini, S. Frilli, U. Pietrini, M. Fanciullacci, and F. Sicuteri, “Acute oral captopril inhibits angiotension converting enzyme activity in human cerebrospinal fluid,” Journal of Hypertension, vol. 5, no. 2, pp. 151–154, 1987. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Tan, J. M. Wang, and F. H. H. Leenen, “Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats,” The American Journal of Hypertension, vol. 18, no. 2, part 1, pp. 158–164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Muders, D. Elsner, K. Jandeleit et al., “Chronic ACE inhibition by quinapril modulates central vasopressinergic system,” Cardiovascular Research, vol. 34, no. 3, pp. 575–581, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Dendorfer, A. Thornagel, W. Raasch, O. Grisk, K. Tempel, and P. Dominiak, “Angiotensin II induces catecholamine release by direct ganglionic excitation,” Hypertension, vol. 40, no. 3, pp. 348–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. G. F. DiBona and S. Y. Jones, “Analysis of renal sympathetic nerve responses to stress,” Hypertension, vol. 25, no. 4, part 1, pp. 531–538, 1995. View at Google Scholar · View at Scopus
  42. A. J. Grippo, J. A. Moffitt, and A. K. Johnson, “Cardiovascular alterations and autonomic imbalance in an experimental model of depression,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 282, no. 5, pp. R1333–R1341, 2002. View at Google Scholar · View at Scopus
  43. D. S. Leong, J. A. Terrón, and A. Falcón-Neri at al, “Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT(1A), AT(1B) and AT(2) receptors,” Neuroendocrinology, vol. 75, no. 4, pp. 227–240, 2002. View at Publisher · View at Google Scholar
  44. F. Muders, D. Elsner, H. Schunkert, G. A. J. Riegger, and M. Palkovits, “Central vasopressin is modulated by chronic blockade of the renin- angiotensin system in experimental left ventricular hypertrophy,” The American Journal of Hypertension, vol. 12, no. 3, pp. 311–314, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. J. V. Gainer, J. D. Morrow, A. Loveland, D. J. King, and N. J. Brown, “Effect of bradykinin-receptor blockade on the response to angiotensin- converting-enzyme inhibitor in normotensive and hypertensive subjects,” The New England Journal of Medicine, vol. 339, no. 18, pp. 1285–1292, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Ito, K. Omata, S. Ito, K. M. Hoagland, and R. J. Roman, “Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 280, no. 3, pp. R822–R830, 2001. View at Google Scholar · View at Scopus
  47. F. Qadri, T. Arens, E.-C. Schwarz, W. Häuser, A. Dendorfer, and P. Dominiak, “Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension,” Journal of Hypertension, vol. 21, no. 9, pp. 1687–1694, 2003. View at Publisher · View at Google Scholar · View at Scopus